10 results
Summary of dosing recommendations in renal impairment of commonly used hypoglycaemic agents

#Diabetes #Diabetic #Medications #Pharmacology #Dosing
Summary of dosing ... #Diabetic #Medications ... #Pharmacology #Dosing ... #Dosing #Renal ... Impairment #CKD #Table
Pharmacologic prophylaxis of VTE in selected clinical scenarios.

Enoxaparin 
Dalteparin 
Fondaparinux 
Dabigatran 
Unfractionated Heparin
Warfarin 
Aspirin 

#prophylaxis #VTE
VTE in selected clinical ... prophylaxis #VTE #DVT #dosing ... #Medications #management ... #indications #pharmacology ... #table
Insulin and analogues onset of action, peak times and duration.

Follow at www.instagram.com/rxnotes for more!

#pharmacology #table #comparison
#pharmacology #table ... #comparison #dosing ... #insulin #diabetes ... #medications #halflife
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
For most indications ... #management #algorithm ... pharmacology #treatment #medications ... #table #pharmacotherapy ... hematology #warfarin #dosing
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Roflumilast) Indication ... Eosinophils < 100 Dosing ... : 250 mcg tablet ... won’t have any clinical ... #Roflumilast #Indications
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
GLP-1 Agonist Dosing ... oral route by using ... drug to remain stable ... take any other medications ... #semaglutide #Diabetes
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
- Allergies to medications ... event, follow ACC algorithm ... Change in clinical ... the type of and indication ... Diabetes regimen
SLE (Systemic Lupus Erythematosus)

Suspect:
Clinical evidence of (fatigue, rash, photosensitivity, inflammatory arthritis, weight loss, and fever) and
) Suspect: Clinical ... Skin Disease Classification ... lymphoproliferative syndrome Clinical ... pancreatitis, protein-losing ... activation and/or medications
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
Prophylaxis): Indications ... disease based on clinical ... please refer to Table ... 5 for dosing recommendation ... Indication for Discontinuing
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
prevent TB disease) Indications ... HIV-infected persons with clinical ... Please refer to the table ... below for TB drug dosing ... Guidelines for dosing